Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.10
MLAB's Cash-to-Debt is ranked lower than
94% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. MLAB: 0.10 )
Ranked among companies with meaningful Cash-to-Debt only.
MLAB' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.05  Med: No Debt Max: No Debt
Current: 0.1
Equity-to-Asset 0.55
MLAB's Equity-to-Asset is ranked lower than
55% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. MLAB: 0.55 )
Ranked among companies with meaningful Equity-to-Asset only.
MLAB' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.51  Med: 0.93 Max: 0.97
Current: 0.55
0.51
0.97
Interest Coverage N/A
MLAB's Interest Coverage is ranked higher than
75% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 39.93 vs. MLAB: N/A )
Ranked among companies with meaningful Interest Coverage only.
MLAB' s Interest Coverage Range Over the Past 10 Years
Min: N/A  Med: 9999.5 Max: No Debt
Current: N/A
N/A
No Debt
Piotroski F-Score: 4
Altman Z-Score: 4.99
Beneish M-Score: -2.45
WACC vs ROIC
3.82%
9.85%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 17.86
MLAB's Operating Margin % is ranked higher than
81% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.65 vs. MLAB: 17.86 )
Ranked among companies with meaningful Operating Margin % only.
MLAB' s Operating Margin % Range Over the Past 10 Years
Min: 17.86  Med: 30.16 Max: 36.1
Current: 17.86
17.86
36.1
Net Margin % 12.24
MLAB's Net Margin % is ranked higher than
80% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.14 vs. MLAB: 12.24 )
Ranked among companies with meaningful Net Margin % only.
MLAB' s Net Margin % Range Over the Past 10 Years
Min: 12.24  Med: 19.1 Max: 23.57
Current: 12.24
12.24
23.57
ROE % 13.19
MLAB's ROE % is ranked higher than
76% of the 162 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.92 vs. MLAB: 13.19 )
Ranked among companies with meaningful ROE % only.
MLAB' s ROE % Range Over the Past 10 Years
Min: 13.19  Med: 17.89 Max: 22.21
Current: 13.19
13.19
22.21
ROA % 7.08
MLAB's ROA % is ranked higher than
75% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.93 vs. MLAB: 7.08 )
Ranked among companies with meaningful ROA % only.
MLAB' s ROA % Range Over the Past 10 Years
Min: 7.08  Med: 14.85 Max: 20.4
Current: 7.08
7.08
20.4
ROC (Joel Greenblatt) % 55.60
MLAB's ROC (Joel Greenblatt) % is ranked higher than
85% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.86 vs. MLAB: 55.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MLAB' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 55.6  Med: 69.89 Max: 80.32
Current: 55.6
55.6
80.32
3-Year Revenue Growth Rate 20.40
MLAB's 3-Year Revenue Growth Rate is ranked higher than
88% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. MLAB: 20.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
MLAB' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 6  Med: 12.4 Max: 24.7
Current: 20.4
6
24.7
3-Year EBITDA Growth Rate 10.80
MLAB's 3-Year EBITDA Growth Rate is ranked higher than
66% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.10 vs. MLAB: 10.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
MLAB' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 3.9  Med: 11 Max: 27.9
Current: 10.8
3.9
27.9
3-Year EPS without NRI Growth Rate 8.10
MLAB's 3-Year EPS without NRI Growth Rate is ranked higher than
56% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. MLAB: 8.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
MLAB' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 4.7  Med: 9.7 Max: 24
Current: 8.1
4.7
24
GuruFocus has detected 3 Warning Signs with Mesa Laboratories Inc $MLAB.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MLAB's 10-Y Financials

Financials (Next Earnings Date: 2017-05-02 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MLAB Guru Trades in Q1 2016

Chuck Royce 59,100 sh (+32.81%)
Jim Simons 136,400 sh (-1.59%)
» More
Q2 2016

MLAB Guru Trades in Q2 2016

Chuck Royce 54,000 sh (-8.63%)
Jim Simons 101,600 sh (-25.51%)
» More
Q3 2016

MLAB Guru Trades in Q3 2016

Jim Simons 94,159 sh (-7.32%)
Chuck Royce 40,300 sh (-25.37%)
» More
Q4 2016

MLAB Guru Trades in Q4 2016

Chuck Royce 40,300 sh (unchged)
Jim Simons 83,300 sh (-11.53%)
» More
» Details

Insider Trades

Latest Guru Trades with MLAB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 334513    SIC: 3823
Compare:NAS:BIOL, NAS:BLFS, NAS:BMRA, NYSE:BAX, NYSE:BDX » details
Mesa Laboratories Inc designs, manufactures and markets quality control instruments and disposable products and also manufactures and markets biological indicators and distributes chemical indicators.

Mesa Laboratories Inc was incorporated under the laws of the State of Colorado on March 26, 1982. The Company is focused on quality control products, which are sold into niche markets that are driven by regulatory requirements. It is organized into three divisions across six physical locations. Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, environmental air sampling and semiconductor industries. Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, hydrogen peroxide, ethylene oxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. Continuous Monitoring Division designs, develops and markets systems which are used to monitor various environmental parameters such as temperature, humidity and differential pressure to ensure that critical storage and processing conditions are maintained in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies and a number of other laboratory and industrial environments. The Lakewood, Colorado, and Butler, New Jersey, facilities manufacture Instruments Division products which include the DataTrace, DialyGuard, DryCal, Torqo, SureTorque and BGI brands. The Omaha, Nebraska, and Bozeman, Montana locations manufacture Biological Indicators Division products which include the Mesa, PCD and Apex brands, while the Lakewood, Colorado, facility also manufactures Continuous Monitoring Division products which include CheckPoint and AmegaView brands. Companies with which Instruments Division products compete include the Myron L Company, IBP Medical GmbH, Amphenol Corporation, Ellab, TMI Orion, Danaher, Inc., Thermo Fisher Scientific, Inc., Mecmesin, Steinfurth, Met One Instruments, Inc. and Tisch Environmental. Biological Indicators Division products compete with 3M, Terragene, NAMSA and Steris, among others. Continuous Monitoring Division systems compete with Rees Scientific Corporation, Amphenol Corporation and Cooper-Atkins, among others. Several products in both the Instruments and Biological Indicators Divisions are medical devices subject to the provisions of the Federal Food, Drug and Cosmetic Act, as amended by the Medical Device Amendments of 1976.

Ratios

vs
industry
vs
history
PE Ratio 39.61
MLAB's PE Ratio is ranked lower than
66% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.58 vs. MLAB: 39.61 )
Ranked among companies with meaningful PE Ratio only.
MLAB' s PE Ratio Range Over the Past 10 Years
Min: 10.41  Med: 19.2 Max: 45.91
Current: 39.61
10.41
45.91
PE Ratio without NRI 39.61
MLAB's PE Ratio without NRI is ranked lower than
67% of the 130 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. MLAB: 39.61 )
Ranked among companies with meaningful PE Ratio without NRI only.
MLAB' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.41  Med: 19.2 Max: 45.91
Current: 39.61
10.41
45.91
Price-to-Owner-Earnings 54.60
MLAB's Price-to-Owner-Earnings is ranked lower than
79% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.68 vs. MLAB: 54.60 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MLAB' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.5  Med: 19.86 Max: 97.93
Current: 54.6
12.5
97.93
PB Ratio 4.74
MLAB's PB Ratio is ranked lower than
67% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.39 vs. MLAB: 4.74 )
Ranked among companies with meaningful PB Ratio only.
MLAB' s PB Ratio Range Over the Past 10 Years
Min: 1.78  Med: 3.29 Max: 5.53
Current: 4.74
1.78
5.53
PS Ratio 4.86
MLAB's PS Ratio is ranked lower than
69% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. MLAB: 4.86 )
Ranked among companies with meaningful PS Ratio only.
MLAB' s PS Ratio Range Over the Past 10 Years
Min: 2.32  Med: 3.94 Max: 6.77
Current: 4.86
2.32
6.77
Price-to-Free-Cash-Flow 153.47
MLAB's Price-to-Free-Cash-Flow is ranked lower than
95% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.63 vs. MLAB: 153.47 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MLAB' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.09  Med: 19.11 Max: 43940
Current: 153.47
10.09
43940
Price-to-Operating-Cash-Flow 33.23
MLAB's Price-to-Operating-Cash-Flow is ranked lower than
79% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.91 vs. MLAB: 33.23 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MLAB' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.85  Med: 16.41 Max: 53.45
Current: 33.23
9.85
53.45
EV-to-EBIT 29.24
MLAB's EV-to-EBIT is ranked lower than
71% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.63 vs. MLAB: 29.24 )
Ranked among companies with meaningful EV-to-EBIT only.
MLAB' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.4  Med: 12.6 Max: 34.1
Current: 29.24
5.4
34.1
EV-to-EBITDA 19.36
MLAB's EV-to-EBITDA is ranked lower than
63% of the 115 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 16.65 vs. MLAB: 19.36 )
Ranked among companies with meaningful EV-to-EBITDA only.
MLAB' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.9  Med: 10.75 Max: 22.6
Current: 19.36
4.9
22.6
PEG Ratio 3.44
MLAB's PEG Ratio is ranked lower than
64% of the 55 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.82 vs. MLAB: 3.44 )
Ranked among companies with meaningful PEG Ratio only.
MLAB' s PEG Ratio Range Over the Past 10 Years
Min: 0.44  Med: 1.31 Max: 4.73
Current: 3.44
0.44
4.73
Shiller PE Ratio 53.24
MLAB's Shiller PE Ratio is ranked lower than
65% of the 46 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 44.61 vs. MLAB: 53.24 )
Ranked among companies with meaningful Shiller PE Ratio only.
MLAB' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.21  Med: 31.87 Max: 59.92
Current: 53.24
16.21
59.92
Current Ratio 1.59
MLAB's Current Ratio is ranked lower than
73% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.37 vs. MLAB: 1.59 )
Ranked among companies with meaningful Current Ratio only.
MLAB' s Current Ratio Range Over the Past 10 Years
Min: 1.44  Med: 10.86 Max: 20.29
Current: 1.59
1.44
20.29
Quick Ratio 0.93
MLAB's Quick Ratio is ranked lower than
79% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. MLAB: 0.93 )
Ranked among companies with meaningful Quick Ratio only.
MLAB' s Quick Ratio Range Over the Past 10 Years
Min: 0.82  Med: 7.82 Max: 16
Current: 0.93
0.82
16
Days Inventory 131.40
MLAB's Days Inventory is ranked lower than
52% of the 156 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.59 vs. MLAB: 131.40 )
Ranked among companies with meaningful Days Inventory only.
MLAB' s Days Inventory Range Over the Past 10 Years
Min: 104  Med: 138.51 Max: 201.41
Current: 131.4
104
201.41
Days Sales Outstanding 50.17
MLAB's Days Sales Outstanding is ranked higher than
74% of the 140 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.14 vs. MLAB: 50.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
MLAB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 50.17  Med: 69.47 Max: 81.01
Current: 50.17
50.17
81.01
Days Payable 26.70
MLAB's Days Payable is ranked lower than
86% of the 129 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 51.97 vs. MLAB: 26.70 )
Ranked among companies with meaningful Days Payable only.
MLAB' s Days Payable Range Over the Past 10 Years
Min: 9.42  Med: 19.03 Max: 35.03
Current: 26.7
9.42
35.03

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.53
MLAB's Dividend Yield % is ranked lower than
81% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.16 vs. MLAB: 0.53 )
Ranked among companies with meaningful Dividend Yield % only.
MLAB' s Dividend Yield % Range Over the Past 10 Years
Min: 0.48  Med: 1.26 Max: 2.6
Current: 0.53
0.48
2.6
Dividend Payout Ratio 0.21
MLAB's Dividend Payout Ratio is ranked higher than
73% of the 85 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. MLAB: 0.21 )
Ranked among companies with meaningful Dividend Payout Ratio only.
MLAB' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.21  Med: 0.24 Max: 0.29
Current: 0.21
0.21
0.29
3-Year Dividend Growth Rate 5.80
MLAB's 3-Year Dividend Growth Rate is ranked lower than
68% of the 63 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.10 vs. MLAB: 5.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
MLAB' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.4 Max: 44.2
Current: 5.8
0
44.2
Forward Dividend Yield % 0.53
MLAB's Forward Dividend Yield % is ranked lower than
87% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. MLAB: 0.53 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.76
MLAB's 5-Year Yield-on-Cost % is ranked lower than
78% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.53 vs. MLAB: 0.76 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
MLAB' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.67  Med: 1.77 Max: 3.65
Current: 0.76
0.67
3.65
3-Year Average Share Buyback Ratio -2.40
MLAB's 3-Year Average Share Buyback Ratio is ranked higher than
51% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. MLAB: -2.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MLAB' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.2  Med: -0.8 Max: 6.5
Current: -2.4
-3.2
6.5

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.34
MLAB's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
61% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. MLAB: 2.34 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MLAB' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.51  Med: 1.13 Max: 2.5
Current: 2.34
0.51
2.5
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.42
MLAB's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
57% of the 21 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.07 vs. MLAB: 2.42 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.23
MLAB's Price-to-Median-PS-Value is ranked lower than
58% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. MLAB: 1.23 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MLAB' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.48  Med: 0.89 Max: 1.56
Current: 1.23
0.48
1.56
Price-to-Peter-Lynch-Fair-Value 4.00
MLAB's Price-to-Peter-Lynch-Fair-Value is ranked lower than
74% of the 42 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.18 vs. MLAB: 4.00 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
MLAB' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.46  Med: 1.39 Max: 4.58
Current: 4
0.46
4.58
Earnings Yield (Greenblatt) % 3.42
MLAB's Earnings Yield (Greenblatt) % is ranked higher than
59% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. MLAB: 3.42 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MLAB' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.9  Med: 7.9 Max: 18.7
Current: 3.42
2.9
18.7
Forward Rate of Return (Yacktman) % 11.85
MLAB's Forward Rate of Return (Yacktman) % is ranked higher than
58% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.62 vs. MLAB: 11.85 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MLAB' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 11.4  Med: 19.7 Max: 30.2
Current: 11.85
11.4
30.2

More Statistics

Revenue (TTM) (Mil) $94.18
EPS (TTM) $ 3.03
Beta0.23
Short Percentage of Float6.76%
52-Week Range $88.40 - 137.20
Shares Outstanding (Mil)3.70
» More Articles for MLAB

Headlines

Articles On GuruFocus.com
Van Den Berg Adds Four Stakes to Portfolio in Second Quarter Jul 14 2015 
Mesa Laboratories Inc. (MLAB) CFO, Secretary Steven W Peterson sells 10,000 Shares Mar 03 2011 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 15 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 16 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 14 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 13 2009 

More From Other Websites
MESA LABORATORIES INC /CO Files SEC form 8-K, Change in Directors or Principal Officers Mar 20 2017
Mesa Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : MLAB-US : March 17,... Mar 17 2017
MESA LABORATORIES INC /CO Files SEC form 8-K, Entry into a Material Definitive Agreement,... Mar 02 2017
Mesa Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : MLAB-US : February... Feb 14 2017
MESA LABORATORIES INC /CO Financials Feb 09 2017
Mesa Laboratories, Inc. :MLAB-US: Earnings Analysis: Q3, 2017 By the Numbers : February 7, 2017 Feb 07 2017
MESA LABORATORIES INC /CO Files SEC form 10-Q, Quarterly Report Feb 06 2017
Mesa Labs posts 3Q profit Feb 02 2017
Mesa Labs posts 3Q profit Feb 02 2017
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Feb 02 2017
Mesa Labs Reports Record Third Quarter Revenues and Adjusted Net Income Feb 02 2017
Mesa Laboratories, Inc. : MLAB-US: Dividend Analysis : November 30th, 2016 (record date) : By the... Jan 25 2017
Mesa Labs Declares Quarterly Dividend Jan 03 2017
Mesa Labs Declares Quarterly Dividend Jan 03 2017
Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : MLAB-US : December... Dec 28 2016
Product Loss Prevention; a Case Study Dec 16 2016
Should You Add One Liberty Properties, Inc. (OLP) to Your Portfolio? Dec 14 2016
Mesa Laboratories, Inc. – Value Analysis (NASDAQ:MLAB) : December 5, 2016 Dec 05 2016
Mesa Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : MLAB-US : December... Dec 02 2016
Mesa’s DryCal Division Releases New FlexCal H Nov 08 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)